Arcadia Biosciences, Inc.
RKDA
$0.92
-$0.11-10.85%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.76M | 4.86M | 5.17M | 5.41M | 5.26M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.76M | 4.86M | 5.17M | 5.41M | 5.26M |
| Cost of Revenue | 3.13M | 3.11M | 3.09M | 3.26M | 3.07M |
| Gross Profit | 1.63M | 1.75M | 2.09M | 2.15M | 2.19M |
| SG&A Expenses | 6.44M | 7.00M | 8.09M | 8.76M | 9.32M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.57M | 10.11M | 11.17M | 12.01M | 12.38M |
| Operating Income | -4.81M | -5.25M | -6.00M | -6.61M | -7.13M |
| Income Before Tax | -9.32M | -2.33M | -5.03M | -7.07M | -762.00K |
| Income Tax Expenses | 8.00K | 8.00K | 8.00K | 8.00K | 8.00K |
| Earnings from Continuing Operations | -9.32 | -2.34 | -5.04 | -7.08 | -0.77 |
| Earnings from Discontinued Operations | -- | -- | -27.00K | -457.00K | -1.25M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.32M | -2.34M | -5.07M | -7.54M | -2.02M |
| EBIT | -4.81M | -5.25M | -6.00M | -6.61M | -7.13M |
| EBITDA | -4.78M | -5.22M | -5.95M | -6.55M | -7.05M |
| EPS Basic | -5.71 | -1.71 | -3.71 | -5.52 | -1.48 |
| Normalized Basic EPS | -3.56 | -2.32 | -3.49 | -4.42 | -2.91 |
| EPS Diluted | -5.73 | -1.72 | -3.72 | -5.52 | -1.93 |
| Normalized Diluted EPS | -2.38 | -1.14 | -2.31 | -3.24 | -2.35 |
| Average Basic Shares Outstanding | 6.19M | 5.47M | 5.47M | 5.46M | 5.46M |
| Average Diluted Shares Outstanding | 7.43M | 6.71M | 6.70M | 6.70M | 7.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |